Canatu Oyj (CNTPF)
| Market Cap | 268.05M -33.0% |
| Revenue (ttm) | 19.61M +406.1% |
| Net Income | -11.39M |
| EPS | -0.34 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 100 |
| Open | 7.59 |
| Previous Close | 8.65 |
| Day's Range | 7.59 - 7.59 |
| 52-Week Range | 7.59 - 13.25 |
| Beta | 0.55 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 25, 2026 |
About Canatu Oyj
Canatu Oyj develops and sells carbon nanotubes (CNTs) and related products, and manufacturing equipment for the semiconductor, automotive, and medical diagnostics industries in Finland, the United States, Japan, and Taiwan. The company offers custom CNT synthesis reactors; CNT membrane for high-power EUV lithography and X-Ray filter applications; EUV pellicies to protect photomask for contamination while permitting high EUV transmission; optical filters for use in X-Ray filter applications; and inspection membranes that enhances quality control... [Read more]
Financial Performance
In 2025, Canatu Oyj's revenue was 16.70 million, an increase of 406.06% compared to the previous year's 3.30 million. Losses were -9.70 million, 169.4% more than in 2024.
Financial numbers in EUR Financial StatementsNews
Canatu Oyj Transcript: CMD 2026
Transitioning from technology validation to scalable value creation, the company targets EUR 100–150 million revenue and 25–30% EBIT margin by 2030, driven by semiconductor growth and recurring revenues. High barriers to entry, disciplined capital allocation, and a flexible business model underpin expansion in automotive and medical diagnostics.
Canatu Oyj Press release: FY 2026
Canatu Oyj issued a press release on March 26, 2026, disclosing material business information to investors.
Canatu Oyj Slides: FY 2026
Canatu Oyj has posted slides in relation to its FY 2026 quarterly earnings report, which was published on March 26, 2026.
Canatu Oyj Earnings Call Transcript: H2 2025
Revenue declined 29% to EUR 15.6 million due to delayed reactor orders, but gross margin improved and automotive revenue more than doubled. Strong cash position enables continued investment, with key operational targets set for 2026 and new long-term guidance to be announced in March.
Canatu Oyj Annual report: H2 2025
Canatu Oyj has published its H2 2025 annual report on March 3, 2026.
Canatu Oyj Quarterly report: H2 2025
Canatu Oyj has published its H2 2025 quarterly earnings report on March 3, 2026.
Canatu Oyj Slides: H2 2025
Canatu Oyj has posted slides in relation to its H2 2025 quarterly earnings report, which was published on March 3, 2026.
Canatu Oyj Earnings Call Transcript: H1 2025
H1 revenue fell 34% year-over-year to $7.3 million due to semiconductor industry delays, but gross margin improved to 67.3%. Strategic investments in new facilities, medical diagnostics, and business development continue, with long-term targets maintained despite increased timeline risk.
Canatu Oyj Quarterly report: H1 2025
Canatu Oyj has published its H1 2025 quarterly earnings report on August 29, 2025.
Canatu Oyj Slides: H1 2025
Canatu Oyj has posted slides in relation to its H1 2025 quarterly earnings report, which was published on August 29, 2025.